Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glycogen Storage Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableApproved For MarketingNCT00520143
What this trial is testing

Alglucosidase Alfa Temporary Access Program

Who this might be right for
Glycogen Storage Disease Type II (GSD-II)Pompe Disease (Late-Onset)Acid Maltase Deficiency Disease+1 more
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00250939
What this trial is testing

RhGAA in Patients With Late-Onset Pompe Disease

Who this might be right for
Pompe Disease (Late-onset)Glycogen Storage Disease Type II (GSD-II)Acid Maltase Deficiency Disease+1 more
Genzyme, a Sanofi Company 5
Testing effectiveness (Phase 2)UnknownNCT06130228
What this trial is testing

Nutritional Therapy in Late-onset Pompe Disease

Who this might be right for
Pompe DiseaseMuscle LossObesity+5 more
McMaster University 28
Not applicableUnknownNCT04476550
What this trial is testing

Clinical Specimen Collection From Pompe Disease Patients

Who this might be right for
Pompe Disease
Serhat Gumrukcu, MD PhD 12
Not applicableLooking for participantsNCT07834320
What this trial is testing

Pompe Disease RWE Long-term Monitoring Program

Who this might be right for
Pompe Disease
National Taiwan University Hospital 40
Not applicableStudy completedNCT02054832
What this trial is testing

Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch

Who this might be right for
Glycogen Storage Disease Type IAGlycogen Storage Disease Type IBGlycogen Storage Disease Type III+1 more
John Mitchell 11
Not applicableLooking for participantsNCT00231400
What this trial is testing

Pompe Disease Registry Protocol

Who this might be right for
Glycogen Storage Disease Type IIPompe Disease
Genzyme, a Sanofi Company 2,000
Not applicableUnknownNCT01482494
What this trial is testing

Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia

Who this might be right for
Pompe Disease
Jordi Perez Lopez 50
Not applicableUnknownNCT02527239
What this trial is testing

Prevalence of Pompe's Disease in Respiratory Clinics

Who this might be right for
Pompe's Disease
Royal Brompton & Harefield NHS Foundation Trust 400
Large-scale testing (Phase 3)Looking for participantsNCT04808505
What this trial is testing

Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

Who this might be right for
Glycogen Storage Disease Type II Infantile Onset
Amicus Therapeutics 36
Not applicableUnknownNCT00713453
What this trial is testing

Muscle Response to Enzyme Replacement Therapy in Pompe Disease

Who this might be right for
Pompe Disease
National Taiwan University Hospital 16
Post-approval studies (Phase 4)Looking for participantsNCT06666413
What this trial is testing

China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

Who this might be right for
Glycogen Storage Disease Type IIPompe's Disease
Genzyme, a Sanofi Company 13
Not applicableEnded earlyNCT02338817
What this trial is testing

Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population

Who this might be right for
Glycogen Storage Disease
University of Florida 9
Large-scale testing (Phase 3)Study completedNCT02782741
What this trial is testing

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II;Pompe's Disease
Genzyme, a Sanofi Company 101
Very early researchEnded earlyNCT02357225
What this trial is testing

A Pilot Study of Pyridostigmine in Pompe Disease

Who this might be right for
Pompe Disease
University of Florida 2
Post-approval studies (Phase 4)Study completedNCT01410890
What this trial is testing

Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease

Who this might be right for
Pompe DiseaseGlycogen Storage Disease Type II (GSD II)
Genzyme, a Sanofi Company 21
Early research (Phase 1)Study completedNCT04226274
What this trial is testing

The Safety of REN001 in Patients With McArdle Disease

Who this might be right for
McArdle Disease
Reneo Pharma Ltd 19
Not applicableLooking for participantsNCT03564561
What this trial is testing

Natural History of Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II, Adult
Assistance Publique - Hôpitaux de Paris 20
Not applicableLooking for participantsNCT05734521
What this trial is testing

Avalglucosidase Alfa Pregnancy Study

Who this might be right for
Pompe DiseasePregnancy
Sanofi 100
Testing effectiveness (Phase 2)Looking for participantsNCT07738107
What this trial is testing

ATR 1072 in Participants With PRKAG2 Syndrome

Who this might be right for
Cardiac GlycogenosisCardiomyopathyHypertrophic+1 more
Atrium Therapeutics 37
Next Page